About 400 reports

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot C.

  • HIV AIDS
  • Pathology
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • France
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United Kingdom
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand
  • 5.3.1.1 OPPORTUNITIES
  • 6.5.3.1 CHINA

The global flow cytometry market is expected to register a CAGR of 7.1% during 2018 to 2023 (the forecast period). Flow cytometry has evolved from a promising new technology to an indispensable tool, and its market is seeing a boom because of its application in the diagnosis of various disorders, like hematological disorders, malignancies,...

  • HIV AIDS
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton Property Group
  • Danaher Corporation

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United Kingdom
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • France
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand

Diagnostic Tests: HIV-##/ ##, HIV Ag, NAT, Western Blot C.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

Diagnostic Tests: HIV-##/ ##, HIV Ag, NAT, Western Blot C.

  • HIV AIDS
  • Pathology
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##, HIV Ag, NAT, Western Blot C.

  • HIV AIDS
  • Pathology
  • France
  • Demand

Diagnostic Tests: HIV-##/ ##, HIV Ag, NAT, Western Blot C.

  • HIV AIDS
  • Pathology
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##, HIV Ag, NAT, Western Blot C.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

Diagnostic Tests: HIV-##/ ##, HIV Ag, NAT, Western Blot C.

  • HIV AIDS
  • Pathology
  • United Kingdom
  • Demand

Diagnostic Tests: HIV-##/ ##, HIV Ag, NAT, Western Blot C.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##, HIV Ag, NAT, Western Blot C.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand
  • 4.1.1 Decreasing HIV related Death Rates
  • GLOBAL HIV PATIENTS DEATH RATE (2012-2016)

AIDS: It is the final and most severe stage of the HIV infection.

  • HIV AIDS
  • World
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • GLOBAL OVERVIEW OF HIV, MEN AND WOMEN, ALL AGES, 1990-2015
  • MM, TOTAL PREVALENT CASES OF HIV, ALL AGES , BOTH SEXES, N, SELECT YEARS, 2015-2025

EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2025 Summary Human immunodeficiency virus (HIV) is a lentivirus that impairs and destructs the CD4 cells of the immune system (Simon et al., 2006). This weakens the immune system, leaving an infected individual more susceptible to other illnesses...

  • HIV AIDS
  • East Asia
  • Japan
  • Forecast
  • UNAIDS

HIV/ AIDS is one of the diseases that is contributing to the high demand for IV catheters, needles, and syringes.

  • HIV AIDS
  • World
  • B. Braun Medical
  • Teleflex Incorporated
  • Terumo Corporation